Can Corporate Support for Research Coexist With Academic Freedom?

To the Editor:

The article on the University of California at Berkeley's research agreement with the Novartis Agricultural Discovery Institute is surprising ("Berkeley Pact With a Swiss Company Takes Technology Transfer to a New Level," December 11). It is surprising not so much because of its attempt to manufacture controversy, but because of the people from whom Goldie Blumenstyk chose to elicit criticism.

Digital or Print Subscription

Already have an account? Log In Now.